Bigdata@heart

launched in march 2017, bigdata@heart is a six-year project of the innovative medicines initiative (imi), an eu public-private consortium consisting of patient networks, learned societies, smes, pharmaceutical companies and academia. bigdata@heart’s ultimate goal is to develop a big data-driven translational research platform of unparalleled scale and phenotypic resolution in order to deliver clinically relevant disease phenotypes, scalable insights from real-world evidence and drivers to drug development and personalised medicine through advanced analytics. the project focuses on atrial fibrillation (af), acute coronary syndrome (acs) and heart failure (hf). the research leading to these results has received support from the eu/efpia innovative medicines initiative [2] joint undertaking bigdata@heart grant n° 116074.